Correlation Between Salesforce and Franklin Genomic
Can any of the company-specific risk be diversified away by investing in both Salesforce and Franklin Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Franklin Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Franklin Genomic Advancements, you can compare the effects of market volatilities on Salesforce and Franklin Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Franklin Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Franklin Genomic.
Diversification Opportunities for Salesforce and Franklin Genomic
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Franklin is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Franklin Genomic Advancements in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Genomic Adv and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Franklin Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Genomic Adv has no effect on the direction of Salesforce i.e., Salesforce and Franklin Genomic go up and down completely randomly.
Pair Corralation between Salesforce and Franklin Genomic
Considering the 90-day investment horizon Salesforce is expected to generate 1.41 times more return on investment than Franklin Genomic. However, Salesforce is 1.41 times more volatile than Franklin Genomic Advancements. It trades about 0.21 of its potential returns per unit of risk. Franklin Genomic Advancements is currently generating about 0.0 per unit of risk. If you would invest 29,889 in Salesforce on August 30, 2024 and sell it today you would earn a total of 3,112 from holding Salesforce or generate 10.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Franklin Genomic Advancements
Performance |
| Timeline |
| Salesforce |
| Franklin Genomic Adv |
Salesforce and Franklin Genomic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Franklin Genomic
The main advantage of trading using opposite Salesforce and Franklin Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Franklin Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Genomic will offset losses from the drop in Franklin Genomic's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Franklin Genomic vs. Artec Consulting Corp | Franklin Genomic vs. Franklin Disruptive Commerce | Franklin Genomic vs. Photronics | Franklin Genomic vs. Global X Genomics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |